Next-Generation Sequencing – Products

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures.

Revvity announced the launch of the Fontus™ Automated Liquid Handling Workstation, designed to deliver easier and faster workflows which enable better results for next generation sequencing (NGS) and diagnostic research applications.

New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow.

Whole transcriptome discovery in the tissue context: Gain a deeper understanding of cellular organization with high-throughput profiling of more than 18,000 genes across whole tissue sections.

PrecisionLife, has announced the results of its long COVID study, providing the first detailed genetic insights into the condition and its commonalities with other diseases, including myalgic encephalomyelitis/chronic fatigue syndrome.

Combined with the Ion Torrent Genexus Integrated Sequencer, new assays deliver valuable genomic insights in the field of aneuploidy analysis.

The Center for Emerging Viral Threats (CEVT) in Louisiana, USA, is using INTEGRA Biosciences’ liquid handling solutions for COVID-19 testing and viral genomics studies.

The rapid and accurate identification of microbial contaminants is crucial for quality control in pharmaceutical processes and products. However, until recently, testing labs have relied on time-consuming phenotypic approaches to ensure that safety standards are met.

Eremid® Genomic Services, LLC (“Eremid”) announces a significant expansion of its in-house sequencing capabilities with the installation of PacBio’s latest HiFi sequencing platform, the Revio.

Bioscientia acquires multiple Revio sequencing systems to revolutionize rare disease research by sequencing thousands of long-read human genomes annually.